Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05222451 · ClinicalTrials.gov registry record · NA
Nutrition for Asthmatics with Obesity
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT05222451: Completed NA study, sponsored by Pennington Biomedical Research Center.
NCT05222451 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05222451, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study will test the effect of diet on asthma in individuals with obesity.
Primary Outcome
Asthma Control Questionnaire score (Juniper; 1 week recall period) Score range: 0-6. Minimally important difference = 0.5.
Interventions
- OTHER DGA Diet
- OTHER MCT Diet
- OTHER KETO Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-06-27 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT05222451 record still lists
NCT05222451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which DGA Diet is the first listed.
NCT05222451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05222451 about?
NCT05222451 is a clinical study titled "Nutrition for Asthmatics with Obesity". This study will test the effect of diet on asthma in individuals with obesity.
What is the current status of trial NCT05222451?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-06-27. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05222451?
The interventions under investigation include: DGA Diet (OTHER), MCT Diet (OTHER), KETO Diet (OTHER).
Who is sponsoring clinical trial NCT05222451?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05222451's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI